SMLR logo

Semler Scientific, Inc. Stock Price

NasdaqCM:SMLR Community·US$405.8m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 36 Fair Values set on narratives written by author

SMLR Share Price Performance

US$26.33
-1.13 (-4.12%)
73.9% undervalued intrinsic discount
US$101.00
Fair Value
US$26.33
-1.13 (-4.12%)
73.9% undervalued intrinsic discount
US$101.00
Fair Value
Price US$26.33
AnalystHighTarget US$101.00
AnalystConsensusTarget US$75.33
AnalystLowTarget US$60.00

SMLR Community Narratives

AnalystHighTarget·
Fair Value US$101 73.9% undervalued intrinsic discount

Aging Population Will Drive Non-Invasive Diagnostic Adoption

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$75.33 65.0% undervalued intrinsic discount

Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks

0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AnalystLowTarget·
Fair Value US$60 56.1% undervalued intrinsic discount

Bitcoin Volatility Will Erode Margins While SaaS Will Offer Hope

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent SMLR News & Updates

Is Semler Scientific (NASDAQ:SMLR) Using Too Much Debt?

Aug 21
Is Semler Scientific (NASDAQ:SMLR) Using Too Much Debt?
User avatar

Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks

Diversification into cardiac disease markets and value-based care tools positions the company for higher recurring revenues and improved long-term margins.

Semler Scientific, Inc. Key Details

US$43.0m

Revenue

US$3.9m

Cost of Revenue

US$39.0m

Gross Profit

US$2.0m

Other Expenses

US$37.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
2.45
Gross Margin
90.84%
Net Profit Margin
86.20%
Debt/Equity Ratio
25.1%

Semler Scientific, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Proven track record and fair value.

3 Risks
3 Rewards

About SMLR

Founded
2007
Employees
79
CEO
Douglas Murphy-Chutorian
WebsiteView website
www.semlerscientific.com

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: -1.3%
  • 3 Months: 7.3%
  • 1 Year: 14.4%
  • Year to Date: 13.5%
Over the last 7 days, the market has dropped 1.3%, driven by a pullback of 2.1% in the Financials sector. In the last year, the market is actually up 14%. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›